Association of antibiotic utilization measures and control of extended-spectrum beta-lactamases (ESBLs) producing bacteria.

Trial Profile

Association of antibiotic utilization measures and control of extended-spectrum beta-lactamases (ESBLs) producing bacteria.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Piperacillin/tazobactam (Primary)
  • Indications Escherichia coli infections; Klebsiella infections
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 27 Dec 2007 The expected completion date for this trial is now 1 Jan 2008 according to ClinicalTrials.gov.
    • 16 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top